Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors.

The receptor tyrosine kinase AXL has emerged in recent years as an potential oncology target due to its over expression in several types of cancers coupled with its ability to promote tumor growth and metastasis. In order to identify small molecule inhibitors of AXL, we built a homology model of its catalytic domain to virtually screen and identify scaffolds displaying an affinity for AXL. Further computational and structure-based design resulted in the synthesis of a series of 2,4,5-trisubstitued pyrimidines which demonstrated potent inhibition of AXL in vitro (IC(50) 19 nM) and strongly inhibited the growth of several pancreatic cell lines.

[1]  R. Verardo,et al.  Gas6 anti-apoptotic signaling requires NF-kappa B activation. , 2001, The Journal of biological chemistry.

[2]  Y. Hitoshi,et al.  R 428 , a Selective Small Molecule Inhibitor of Axl Kinase , Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer , 2010 .

[3]  E. Liu,et al.  Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase , 1996, Molecular and cellular biology.

[4]  J. Zha,et al.  Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis , 2009, Oncogene.

[5]  R. Weimer,et al.  An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies , 2010, Oncogene.

[6]  R. Verardo,et al.  Gas6 Anti-apoptotic Signaling Requires NF-κB Activation* , 2001, The Journal of Biological Chemistry.

[7]  H. Earp,et al.  Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors , 2010, Expert opinion on therapeutic targets.

[8]  G. Feldmann,et al.  The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target , 2009, Cancer biology & therapy.

[9]  H. Seno,et al.  Growth arrest‐specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway , 2007, Molecular carcinogenesis.

[10]  B. Hjelle,et al.  Transforming genes in chronic myelogenous leukemia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  澤武 建雄.  Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway , 2006 .

[12]  Pamela F. Jones,et al.  The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases , 1995, Cell.

[13]  C. Basilico,et al.  A putative receptor tyrosine kinase with unique structural topology. , 1991, Oncogene.

[14]  Y. Hitoshi,et al.  R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. , 2010, Cancer research.

[15]  Ruben Abagyan,et al.  ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..